Recent developments in oncology continue to offer promise for patients. Investigators are intensely exploring novel approaches, including immune therapies , targeted therapies , and individualized healthcare . A significant study published this week demonstrates the efficacy of a emerging drug in managing late-stage NSCLC. Furthermore, current tria